Mitotic cell phase enrichment and ionizing radiation
NL2039212B1Active Publication Date: 2026-06-23STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Patent Information
- Authority / Receiving Office
- NL · NL
- Patent Type
- Patents
- Current Assignee / Owner
- STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- Filing Date
- 2024-12-02
- Publication Date
- 2026-06-23
Abstract
A B S T R A C T The invention relates to a combination therapy comprising administering a mitotic- phase (M-phase) cell cycle arresting compound and a modulator of an interphase cell cycle checkpoint to a subject and delivering ionizing radiation to the same subject for the treatment of a tumor. Provided is for (M-phase) cell cycle arresting compounds, modulators of an interphase cell cycle checkpoint and ionizing radiation for use in such treatments, as well as methods of the treatment involving the use of (M-phase) cell cycle arresting compounds and modulators of an interphase cell cycle checkpoint and ionizing radiation.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Sulfonamide derivatives
EP0472053A2
HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
EP1869020A1
Dihydropyrazolopyrimidinone derivatives
EP2016080A1
Compounds useful for inhibiting chk1
EP2379532B1
Compounds useful as inhibitors of ATR kinase
EP2941432A1